Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced the primary endpoint was met in the VISTAS Phase 2b study evaluating volixibat, an investigational oral ...
FILSPARI achieved record 993 new PSFs for IgAN in the U.S. in the first quarter; U.S. net product sales grew 88% year over ...
The Nation (PK) on MSN
35 modern clinics made operational to facilitate Pakistani pilgrims in Saudi Arabia: Abdul Wahab Soomro
Director General Hajj Jeddah Abdul Wahab Soomro has announced the phased establishment of 35 modern clinics in Makkah and Medinah to provide comprehensive health facilities to 119,000 Pakistani ...
Dr. Christine Bjorndal, ND Subheadline A six-year case study demonstrating the role of nutrition, lifestyle, and ...
A newly discovered type of liver cell may hold clues for treating severe liver disease, according to a recent study from the University of Michigan Life Sciences Institute. The findings, published in ...
A new study from Karolinska Institutet shows that an enzyme in the liver may partly explain sex differences in the body's ...
Lancet Liver Commission, published in December, 2021, highlighted that liver disease was the second leading cause of years-of-working-life-lost in Europe (after ischaemic heart disease). The ...
It is not every day that someone tells you they have “a passion for liver disease, especially end-stage liver disease”. But that is exactly how Patrizia Burra, a Co-Chair of the second European ...
A daily ritual for lasting vitality, the Dose of Vitality smoothie - powered by Dose for your Liver® - will be available at ...
Experts think certain non-routine tests are worth asking your doctor about, since the results could point to health-saving ...
VEPPANU™ is the first-and-only FDA-approved PROTAC, a type of heterobifunctional protein degrader –– Approval received in advance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results